908 Devices Inc.
MASS908 Devices Inc.
NASDAQ
Healthcare
Medical - Devices
$6.64
+0.43(6.9%)
52W $3.63 – $9.15
AI-generated
908 Devices Inc.
$248MMkt Cap
$58MRev TTM
$20MNI TTM
11.4xP/E TTM
Latest Earnings
10-K
FY FY2025Mar 8, 2026908 Devices Inc. reported FY 2025 revenue of $56.2 million, an increase from $47.7 million in FY 2024. The company achieved a net income attributable to common stockholders of $19.5 million, a significant improvement from a net loss of $72.2 million in the prior year. This result was driven by a $52.8 million net gain from discontinued operations related to...
What Changed Recently
Fundamentals
How The Business Makes Money
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Industry Medical - Devices
Analyst View
Company Profile
CIK0001555279
ISINUS65443P1021
CUSIP65443P102
Phone857 254 1500
Address645 Summer Street, Boston, MA, 02210, US
SEC EDGAR